Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 227

Cited In for PubMed (Select 2156265)

1.

AAV's Golden Jubilee.

Muzyczka N, Berns KI.

Mol Ther. 2015 May;23(5):807-8. doi: 10.1038/mt.2015.55. No abstract available.

PMID:
25943495
2.

Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success-a personal perspective.

Hastie E, Samulski RJ.

Hum Gene Ther. 2015 May;26(5):257-65. doi: 10.1089/hum.2015.025. Epub 2015 Apr 20.

PMID:
25807962
3.

Adeno-associated virus-mediated microRNA delivery and therapeutics.

Xie J, Burt DR, Gao G.

Semin Liver Dis. 2015 Feb;35(1):81-8. doi: 10.1055/s-0034-1397352. Epub 2015 Jan 29.

4.
5.

Adeno-associated virus type 2 wild-type and vector-mediated genomic integration profiles of human diploid fibroblasts analyzed by third-generation PacBio DNA sequencing.

Hüser D, Gogol-Döring A, Chen W, Heilbronn R.

J Virol. 2014 Oct;88(19):11253-63. doi: 10.1128/JVI.01356-14. Epub 2014 Jul 16.

6.
7.

Adeno-associated virus Rep represses the human integration site promoter by two pathways that are similar to those required for the regulation of the viral p5 promoter.

Dutheil N, Smith SC, Agúndez L, Vincent-Mistiaen ZI, Escalante CR, Linden RM, Henckaerts E.

J Virol. 2014 Aug;88(15):8227-41. doi: 10.1128/JVI.00412-14. Epub 2014 May 14.

8.

Antisense gene silencing: therapy for neurodegenerative disorders?

Nielsen TT, Nielsen JE.

Genes (Basel). 2013 Sep 10;4(3):457-84. doi: 10.3390/genes4030457.

9.

Adeno-associated virus structural biology as a tool in vector development.

Drouin LM, Agbandje-McKenna M.

Future Virol. 2013 Dec;8(12):1183-1199.

10.

Adeno-associated virus type 2 preferentially integrates single genome copies with defined breakpoints.

Janovitz T, Sadelain M, Falck-Pedersen E.

Virol J. 2014 Jan 27;11:15. doi: 10.1186/1743-422X-11-15.

11.

The potential of adeno-associated viral vectors for gene delivery to muscle tissue.

Wang D, Zhong L, Nahid MA, Gao G.

Expert Opin Drug Deliv. 2014 Mar;11(3):345-64. doi: 10.1517/17425247.2014.871258. Epub 2014 Jan 3. Review.

12.

Highly divergent integration profile of adeno-associated virus serotype 5 revealed by high-throughput sequencing.

Janovitz T, Oliveira T, Sadelain M, Falck-Pedersen E.

J Virol. 2014 Mar;88(5):2481-8. doi: 10.1128/JVI.03419-13. Epub 2013 Dec 11.

13.

Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications.

Fiandaca MS, Bankiewicz KS, Federoff HJ.

Pharmaceuticals (Basel). 2012 Jun 4;5(6):553-90. doi: 10.3390/ph5060553.

14.

Viral and Cellular Components of AAV2 Replication Compartments.

Vogel R, Seyffert M, Pereira Bde A, Fraefel C.

Open Virol J. 2013 Oct 31;7:98-120. doi: 10.2174/1874357901307010098. eCollection 2013.

15.

Birth of a new therapeutic platform: 47 years of adeno-associated virus biology from virus discovery to licensed gene therapy.

Flotte TR.

Mol Ther. 2013 Nov;21(11):1976-81. doi: 10.1038/mt.2013.226. No abstract available.

16.

RD2-MolPack-Chim3, a packaging cell line for stable production of lentiviral vectors for anti-HIV gene therapy.

Stornaiuolo A, Piovani BM, Bossi S, Zucchelli E, Corna S, Salvatori F, Mavilio F, Bordignon C, Rizzardi GP, Bovolenta C.

Hum Gene Ther Methods. 2013 Aug;24(4):228-40. doi: 10.1089/hgtb.2012.190. Epub 2013 Aug 3.

17.

Engineered proteins with Pumilio/fem-3 mRNA binding factor scaffold to manipulate RNA metabolism.

Wang Y, Wang Z, Tanaka Hall TM.

FEBS J. 2013 Aug;280(16):3755-67. doi: 10.1111/febs.12367. Epub 2013 Jun 24. Review.

18.

High-throughput sequencing reveals principles of adeno-associated virus serotype 2 integration.

Janovitz T, Klein IA, Oliveira T, Mukherjee P, Nussenzweig MC, Sadelain M, Falck-Pedersen E.

J Virol. 2013 Aug;87(15):8559-68. doi: 10.1128/JVI.01135-13. Epub 2013 May 29.

19.

Random Insertion of mCherry Into VP3 Domain of Adeno-associated Virus Yields Fluorescent Capsids With no Loss of Infectivity.

Judd J, Wei F, Nguyen PQ, Tartaglia LJ, Agbandje-McKenna M, Silberg JJ, Suh J.

Mol Ther Nucleic Acids. 2012 Nov 13;1:e54. doi: 10.1038/mtna.2012.46.

20.

Transgenic models of Alzheimer's disease: better utilization of existing models through viral transgenesis.

Platt TL, Reeves VL, Murphy MP.

Biochim Biophys Acta. 2013 Sep;1832(9):1437-48. doi: 10.1016/j.bbadis.2013.04.017. Epub 2013 Apr 22. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk